Paper40973013
Cardiac hypertrophy at the crossroads: Mechanistic insights and emerging multimodal therapeutic strategies.
Kannan D and 3 others. Eur J Pharmacol, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Cardiac hypertrophy at the crossroads: Mechanistic insights and emerging multimodal therapeutic strategies. Papers, record 40973013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40973013
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cardiac hypertrophy at the crossroads: Mechanistic insights and emerging multimodal therapeutic strategies.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiomegaly | Major topic |
| Humans | |
| Animals | |
| Combined Modality Therapy | |
| Genetic Therapy |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 HL141345 | NHLBI NIH HHS | United States | R01HL141345 | PubMed |
Source NIH RePORTER
References109
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18629360 | Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention. | Vasc Health Risk Manag | 2008 | https://conductscience.org/library/papers/18629360 | PubMed |
| 2 | 37443814 | The Microenvironment of the Pathogenesis of Cardiac Hypertrophy. | Cells | 2023 | https://conductscience.org/library/papers/37443814 | PubMed |
| 3 | 34194329 | Loganin Inhibits Angiotensin II-Induced Cardiac Hypertrophy Through the JAK2/STAT3 and NF-κB Signaling Pathways. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34194329 | PubMed |
| 4 | 18096818 | Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. | Circ Res | 2008 | https://conductscience.org/library/papers/18096818 | PubMed |
| 5 | 35642640 | MicroRNAs as therapeutic targets in cardiovascular disease. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35642640 | PubMed |
| 6 | 11181961 | Cytoplasmic signaling pathways that regulate cardiac hypertrophy. | Annu Rev Physiol | 2001 | https://conductscience.org/library/papers/11181961 | PubMed |
| 7 | 17082763 | TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. | EMBO J | 2006 | https://conductscience.org/library/papers/17082763 | PubMed |
| 8 | 30012983 | A Novel Class of tRNA-Derived Small Non-Coding RNAs Respond to Myocardial Hypertrophy and Contribute to Intergenerational Inheritance. | Biomolecules | 2018 | https://conductscience.org/library/papers/30012983 | PubMed |
| 9 | 17973781 | HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study. | Eur J Clin Invest | 2007 | https://conductscience.org/library/papers/17973781 | PubMed |
| 10 | 32669717 | Investigation of the safety and feasibility of AAV1/SERCA2a gene transfer in patients with chronic heart failure supported with a left ventricular assist device - the SERCA-LVAD TRIAL. | Gene Ther | 2020 | https://conductscience.org/library/papers/32669717 | PubMed |
| 11 | 31982428 | LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis. | J Mol Cell Cardiol | 2020 | https://conductscience.org/library/papers/31982428 | PubMed |
| 12 | 26683870 | Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. | Stem Cells Transl Med | 2016 | https://conductscience.org/library/papers/26683870 | PubMed |
| 13 | 30635403 | Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30635403 | PubMed |
| 14 | 31427727 | Counter-regulatory renin-angiotensin system in cardiovascular disease. | Nat Rev Cardiol | 2020 | https://conductscience.org/library/papers/31427727 | PubMed |
| 15 | 27082978 | Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy. | PLoS One | 2016 | https://conductscience.org/library/papers/27082978 | PubMed |
| 16 | 28912181 | Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. | Circ Res | 2017 | https://conductscience.org/library/papers/28912181 | PubMed |
| 17 | 22750195 | Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets. | Pharmacol Ther | 2012 | https://conductscience.org/library/papers/22750195 | PubMed |
| 18 | 27618650 | The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy. | Nat Med | 2016 | https://conductscience.org/library/papers/27618650 | PubMed |
| 19 | 30569169 | Construction and analysis of the lncRNA‑miRNA‑mRNA network based on competitive endogenous RNA reveals functional genes in heart failure. | Mol Med Rep | 2019 | https://conductscience.org/library/papers/30569169 | PubMed |
| 20 | 30227820 | Three Generations of β-blockers: History, Class Differences and Clinical Applicability. | Curr Hypertens Rev | 2019 | https://conductscience.org/library/papers/30227820 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42633326 | Advances in FGF/FGFR Signaling: Implications for Disease and Therapy. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42633326 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40973013
GET https://conductscience.org/api/papers/v1/40973013/references?page=2